GlassScriptPhysician profile
David E Goldrath
NPI 1255443537
$1,694.27
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $745 · 2020: $141 · 2021: $629 · 2022: $180.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $274.25 | 2019-2021 | |
| Boston Scientific Corporation | $260.48 | 2019-2021 | |
| Myovant Sciences INC. | $179.37 | 2021-2022 | |
| Janssen Biotech, INC. | $145.70 | 2019-2020 | |
| Abbvie INC. | $135.08 | 2019 | |
| Rochester Medical Corporation | $110.79 | 2021 | |
| Amgen INC. | $105.89 | 2019-2021 | |
| Coloplast Corp | $96.69 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $63.14 | 2022 | |
| Pfizer INC. | $41.90 | 2019 | |
| Clarus Therapeutics INC. | $30.07 | 2021 | |
| Urogen Pharma, INC. | $29.64 | 2020 | |
| Intuitive Surgical, INC. | $29.52 | 2021 | |
| Travere Therapeutics, INC. | $24.86 | 2021 | |
| Blue Earth Diagnostics | $20.04 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.82 | 2020 | |
| Allergan, INC. | $17.19 | 2021 | |
| Dendreon Pharmaceuticals LLC | $16.97 | 2019 | |
| Ferring Pharmaceuticals INC. | $16.11 | 2019 | |
| Olympus America INC. | $15.03 | 2020 | |
| Antares Pharma, INC. | $13.94 | 2021 | |
| Zyla Life Sciences, INC. | $13.64 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $12.08 | 2019 | |
| Neotract INC. | $11.75 | 2019 | |
| Myriad Genetic Laboratories, INC. | $11.32 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Goldrath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.